AAD: Awaiting FDA decision in psoriasis, UCB touts 48-week data for bimekizumab in hidradenitis suppurativa zbecker Mon, 03/20/2023 – 11:19 More: AAD: Awaiting FDA decision in psoriasis, UCB touts 48-week data for bimekizumab in hidradenitis suppurativa Source: fierce
read moreCalifornia invests $50M to partner with Civica Rx on insulin manufacturing kdunleavy Mon, 03/20/2023 – 11:15 More: California invests M to partner with Civica Rx on insulin manufacturing Source: fierce
read moreEli Lilly CEO racked up $21.4M in 2022 pay as stock price hit all-time high aliu Mon, 03/20/2023 – 10:51 More: Eli Lilly CEO racked up .4M in 2022 pay as stock price hit all-time high Source: fierce
read moreNovo Nordisk, Eli Lilly replenish Type 2 diabetes stars Ozempic, Mounjaro after off-label weight-loss boom fkansteiner Mon, 03/20/2023 – 10:09 More: Novo Nordisk, Eli Lilly replenish Type 2 diabetes stars Ozempic, Mounjaro after off-label weight-loss boom Source: fierce
read moreHorizon draws comparison of weeds in a garden to gout in new campaign sharon.coey Mon, 03/20/2023 – 09:42 More: Horizon draws comparison of weeds in a garden to gout in new campaign Source: fierce
read moreCombination therapy treat patients with metastatic castration-resistant prostate cancer More: AstraZeneca and MSD’s Lynparza gets green light Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals